| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Hyunchul Lee, Catherine A Leamey, Atomu Sawatar. Rapid reversal of chondroitin sulfate proteoglycan associated staining in subcompartments of mouse neostriatum during the emergence of behaviour. PloS one. vol 3. issue 8. 2008-12-18. PMID:18714376. |
the neostriatum, the mouse homologue of the primate caudate/putamen, is the input nucleus for the basal ganglia, receiving both cortical and dopaminergic input to each of its sub-compartments, the striosomes and matrix. |
2008-12-18 |
2023-08-12 |
mouse |
| Jonathan Moss, J Paul Bola. A dopaminergic axon lattice in the striatum and its relationship with cortical and thalamic terminals. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 28. issue 44. 2008-11-18. PMID:18971464. |
interactions between glutamatergic corticostriatal afferents and dopaminergic nigrostriatal afferents are central to basal ganglia function. |
2008-11-18 |
2023-08-12 |
rat |
| Massimiliano Di Filippo, Barbara Picconi, Alessandro Tozzi, Veronica Ghiglieri, Aroldo Rossi, Paolo Calabres. The endocannabinoid system in Parkinson's disease. Current pharmaceutical design. vol 14. issue 23. 2008-11-17. PMID:18781984. |
parkinson's disease (pd) is a chronic and progressive neurodegenerative disorder of largely unknown etiology caused by a pathological cascade resulting in the degeneration of midbrain dopaminergic neurons of the substantia nigra pars compacta (snpc) projecting to the nucleus striatum, the main input station of the basal ganglia neuronal circuit. |
2008-11-17 |
2023-08-12 |
Not clear |
| Massimiliano Di Filippo, Barbara Picconi, Alessandro Tozzi, Veronica Ghiglieri, Aroldo Rossi, Paolo Calabres. The endocannabinoid system in Parkinson's disease. Current pharmaceutical design. vol 14. issue 23. 2008-11-17. PMID:18781984. |
the components of the endocannabinoid (ecb) system are highly expressed at different levels in the basal ganglia neural circuit where they bidirectionally interact with dopaminergic, glutamatergic and gabaergic signaling systems. |
2008-11-17 |
2023-08-12 |
Not clear |
| Darcy Litteljohn, Emily N Mangano, Shawn Hayle. Cyclooxygenase-2 deficiency modifies the neurochemical effects, motor impairment and co-morbid anxiety provoked by paraquat administration in mice. The European journal of neuroscience. vol 28. issue 4. 2008-10-20. PMID:18657183. |
parkinson's disease and other motor disorders of midbrain basal ganglia dopaminergic functioning are often characterized by alterations of brainstem and limbic systems with accompanying co-morbid anxiety and depressive symptoms. |
2008-10-20 |
2023-08-12 |
mouse |
| Lauri T Haltia, Juha O Rinne, Semi Helin, Riitta Parkkola, Kjell Någren, Valtteri Kaasine. Effects of intravenous placebo with glucose expectation on human basal ganglia dopaminergic function. Synapse (New York, N.Y.). vol 62. issue 9. 2008-09-18. PMID:18566972. |
effects of intravenous placebo with glucose expectation on human basal ganglia dopaminergic function. |
2008-09-18 |
2023-08-12 |
human |
| K Mukhida, M Hong, G B Miles, T Phillips, B A Baghbaderani, M McLeod, N Kobayashi, A Sen, L A Behie, R M Brownstone, I Mende. A multitarget basal ganglia dopaminergic and GABAergic transplantation strategy enhances behavioural recovery in parkinsonian rats. Brain : a journal of neurology. vol 131. issue Pt 8. 2008-09-15. PMID:18669492. |
a multitarget basal ganglia dopaminergic and gabaergic transplantation strategy enhances behavioural recovery in parkinsonian rats. |
2008-09-15 |
2023-08-12 |
human |
| K Mukhida, M Hong, G B Miles, T Phillips, B A Baghbaderani, M McLeod, N Kobayashi, A Sen, L A Behie, R M Brownstone, I Mende. A multitarget basal ganglia dopaminergic and GABAergic transplantation strategy enhances behavioural recovery in parkinsonian rats. Brain : a journal of neurology. vol 131. issue Pt 8. 2008-09-15. PMID:18669492. |
the current transplantation paradigm for parkinson's disease that places foetal dopaminergic cells in the striatum neither normalizes neuronal activity in basal ganglia structures such as the substantia nigra (sn) and subthalamic nucleus (stn) nor leads to complete functional recovery. |
2008-09-15 |
2023-08-12 |
human |
| Samuel D Gale, Abigail L Person, David J Perke. A novel basal ganglia pathway forms a loop linking a vocal learning circuit with its dopaminergic input. The Journal of comparative neurology. vol 508. issue 5. 2008-08-01. PMID:18398824. |
a novel basal ganglia pathway forms a loop linking a vocal learning circuit with its dopaminergic input. |
2008-08-01 |
2023-08-12 |
Not clear |
| I G Sil'ki. The role of dopamine-dependent negative feedback in the hippocampus-basal ganglia-thalamus-hippocampus loop in the extinction of responses. Neuroscience and behavioral physiology. vol 38. issue 4. 2008-07-24. PMID:18401733. |
the direct pathway via the basal ganglia mediates disinhibition of the thalamic nucleus reuniens, exciting neurons in field ca1, which leads to extinction of the responses of hippocampal neurons, decreases in disinhibition of dopaminergic cells, and further extinction of their responses. |
2008-07-24 |
2023-08-12 |
Not clear |
| Christof Brücke, Florian Kempf, A Kupsch, Gerd-Helge Schneider, Joachim K Krauss, Tipu Aziz, Kielan Yarrow, Alek Pogosyan, Peter Brown, Andrea A Küh. Movement-related synchronization of gamma activity is lateralized in patients with dystonia. The European journal of neuroscience. vol 27. issue 9. 2008-07-01. PMID:18430031. |
gamma activity increases after dopaminergic therapy and during voluntary movement, suggesting that it might be physiological and relate to motor processing in the basal ganglia (bg). |
2008-07-01 |
2023-08-12 |
Not clear |
| M A Cenci, H S Lindgre. Advances in understanding L-DOPA-induced dyskinesia. Current opinion in neurobiology. vol 17. issue 6. 2008-06-20. PMID:18308560. |
the crucial role of dopamine (da) in movement control is illustrated by the spectrum of motor disorders caused by either a deficiency or a hyperactivity of dopaminergic transmission in the basal ganglia. |
2008-06-20 |
2023-08-12 |
Not clear |
| Eric A Zilli, Michael E Hasselm. A model of behavioral treatments for self-mutilation behavior in Lesch-Nyhan syndrome. Neuroreport. vol 19. issue 4. 2008-06-13. PMID:18287946. |
we show that the temporal difference learning algorithm that has been often used to interpret dopaminergic activity in the basal ganglia offers an explanation for the self-mutilation behaviors. |
2008-06-13 |
2023-08-12 |
Not clear |
| Patrick B Woo. Role of central dopamine in pain and analgesia. Expert review of neurotherapeutics. vol 8. issue 5. 2008-06-04. PMID:18457535. |
recent insights have demonstrated a central role for dopaminergic neurotransmission in modulating pain perception and natural analgesia within supraspinal regions, including the basal ganglia, insula, anterior cingulate cortex, thalamus and periaqueductal gray. |
2008-06-04 |
2023-08-12 |
Not clear |
| R M Kostrzewa, J P Kostrzewa, R A Kostrzewa, P Nowak, R Bru. Pharmacological models of ADHD. Journal of neural transmission (Vienna, Austria : 1996). vol 115. issue 2. 2008-05-30. PMID:17994186. |
on the basis of genetic models and the noted animal models, monoaminergic phenotypes appear to most-closely attend the behavioral dysfunctions, notably dopaminergic, noradrenergic and serotoninergic systems in forebrain (basal ganglia, nucleus accumbens, prefrontal cortex). |
2008-05-30 |
2023-08-12 |
Not clear |
| J T O'Brie. Role of imaging techniques in the diagnosis of dementia. The British journal of radiology. vol 80 Spec No 2. 2008-05-15. PMID:18445747. |
regionally distinct patterns of hypoperfusion on single-photon emission computed tomography (spect) or hypometabolism on positron emission tomography (pet) can help differentiate ftd, ad and vad, and dopaminergic loss in the basal ganglia can differentiate dlb from ad. |
2008-05-15 |
2023-08-12 |
Not clear |
| Szabolcs Kér. Interactive memory systems and category learning in schizophrenia. Neuroscience and biobehavioral reviews. vol 32. issue 2. 2008-05-02. PMID:17854895. |
whereas executive and declarative memory dysfunctions are well known in schizophrenia, habit learning deficits related to the basal ganglia are less clear, despite the fact that dopaminergic and other neurochemical processes in the basal ganglia may play a crucial role in the pathophysiology and pharmacology of schizophrenia. |
2008-05-02 |
2023-08-12 |
Not clear |
| Carol A Sege. How do the basal ganglia contribute to categorization? Their roles in generalization, response selection, and learning via feedback. Neuroscience and biobehavioral reviews. vol 32. issue 2. 2008-05-02. PMID:17919725. |
the third aspect of categorization discussed is how categories are learned with the aid of feedback linked dopaminergic projections to the basal ganglia. |
2008-05-02 |
2023-08-12 |
Not clear |
| R Exley, S J Crag. Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmission. British journal of pharmacology. vol 153 Suppl 1. 2008-04-28. PMID:18037926. |
both mesostriatal dopaminergic neurons and striatal cholinergic interneurons play key roles in motivational and sensorimotor processing by the basal ganglia. |
2008-04-28 |
2023-08-12 |
Not clear |
| S Kéri, H Nagy, C E Myers, G Benedek, D Shohamy, M A Gluc. Risk and protective haplotypes of the alpha-synuclein gene associated with Parkinson's disease differentially affect cognitive sequence learning. Genes, brain, and behavior. vol 7. issue 1. 2008-04-22. PMID:17451452. |
because stimulus-reward learning may be mediated by the basal ganglia and context learning may be related to the medial temporal lobe, our data raise the possibility that dopaminergic signals regulated by snca inversely affect these memory systems. |
2008-04-22 |
2023-08-12 |
human |